Fig. 1 · Structure
Documents & Downloads
Efbemalenograstim alfa
Recombinant Fusion Protein
Efbemalenograstim alfa is a recombinant fusion protein designed to act as a long-acting dimeric granulocyte colony-stimulating factor (G-CSF). This compound consists of two human G-CSF molecules linked to a human immunoglobulin G2 (hIgG2)-Fc fragment via a peptide linker. Efbemalenograstim alfa effectively stimulates the production of white blood cells, making it valuable in research focused on hematopoiesis and immune response modulation.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| CAS Number | 2200269-79-8 |
| Applications | Recombinant Fusion Protein |
| Molecular Weight | 89.24 kDa |
| Synonyms | Benegrastim; Bineuta; F 627 |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.